Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.42509 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.34741 | 54 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.34842 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.30237 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.25874 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.50702 | 56 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.40438 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.31271 | 54 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.30119 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.31265 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.3333 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.28468 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.34482 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.33781 | 54 |